Current Capital Participates in the Successful Sale of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Current Capital Participates in the Successful Sale of Leading Automotive Supplier Stackpole International

NEW YORK, Oct. 11, 2013 (GLOBE NEWSWIRE) -- Current Capital LLC ("Current Capital"), a private equity investing and management services firm focused on middle market and smaller companies in the industrial and services industries, announced the sale of Stackpole International ("Stackpole") to funds managed by Crestview Partners, a private equity firm with approximately $4 billion of capital under management. Stackpole is a leading designer and manufacturer of highly engineered oil pumps and powdered metal components for automotive manufacturers and other customers.

Current Capital participated in the August 2011 acquisition of Stackpole from Gates Corporation, a subsidiary of Tomkins Ltd., with The Sterling Group, Inc. ("Sterling"), the majority investor in Stackpole. Current Capital and Sterling have helped to transition Stackpole from a division of a large company to an independent global automotive supplier. Over the past two years, Stackpole has continued to win and execute well on oil pump and powdered metal platforms, established a strategic presence in Europe and Asia, accelerated its presence in non-automotive products, achieved operating efficiencies and capitalized on an increasingly strong global automotive production environment.

Jonathan Foster, Founder and Managing Director of Current Capital, commented, "It has been a privilege to work with Peter Ballantyne, President and CEO of Stackpole, and his entire team to help the company continue to grow. This investment has been consistent with our focus on companies that can benefit from our industry knowledge, operating experience, financial expertise and strategic perspective. We are delighted that Stackpole has a high quality new owner with the experience and capital to help the company continue to prosper."

Kent Wallace, a Partner of Sterling, noted, "We are pleased to have worked closely with the entire Stackpole team and Current Capital to build on the company's leadership position for consistently manufacturing and delivering critical components for automotive manufacturers and other customers worldwide. Current Capital is a valued partner that provided automotive knowledge, input on capital issues and a long-term perspective.

About Current Capital LLC

Current Capital LLC ("Current Capital") is a private equity investing and management services firm founded in 2008 by former Fortune 500 executives and investment professionals. The firm's private equity investing business helps create value, primarily in middle market and smaller companies in the industrial and services industries, with an integrated operating, finance and investment approach. Its primary focus is on control investments. However, it will make minority investments where it has significant influence. Current Capital's management services effort manages investments, serves on Boards of Directors and does related consulting for other investors and financial institutions and also provides expert witness services in complex corporate litigation. Please visit www.currentcap.com for more information.

About Stackpole International

Founded in 1952 and headquartered in Ancaster, Ontario, Stackpole is a designer and manufacturer, and often a sole source provider, of highly-engineered oil pumps and powdered metal components for automotive original equipment manufacturers. These components are typically specified on long-term engine and transmission platforms with 10 to 15 year lives and are found on some 400 different vehicles or nameplates. Stackpole's automotive customers rely on the company's ability to design and produce highly durable components for their most important and widely marketed platforms. The company is one of the top automotive oil pump producers in the world. It pioneered variable vane oil pump technology, a design that saves energy by allowing variable rather than fixed pump displacement. It is also a leading fabricator of complex powdered metal components, including gears, sprockets, assemblies and pump components. Stackpole has twelve manufacturing facilities and technical centers in North America, Europe, China and Korea.

MFD Communications for Current Capital LLC Melissa Daly 646-322-9192

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading